{"nctId":"NCT00603291","briefTitle":"BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus","startDateStruct":{"date":"2007-12"},"conditions":["Obesity"],"count":604,"armGroups":[{"label":"Lorcaserin 10 mg QD","type":"EXPERIMENTAL","interventionNames":["Drug: Lorcaserin 10 mg once daily (QD)"]},{"label":"Lorcaserin 10 mg BID","type":"EXPERIMENTAL","interventionNames":["Drug: Lorcaserin 10 mg twice a day (BID)"]},{"label":"Matching Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Matching Placebo"]}],"interventions":[{"name":"Lorcaserin 10 mg once daily (QD)","otherNames":["APD356"]},{"name":"Lorcaserin 10 mg twice a day (BID)","otherNames":["APD356"]},{"name":"Matching Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Overweight/obese men and women with type 2 diabetes mellitus that is managed with oral anti-hyperglycemic agent(s).\n* Body mass index (BMI) 27 to 45 kg/m2, inclusive.\n* Ability to complete a 1 year study\n\nExclusion Criteria:\n\n* Pregnancy\n* Use of insulin in any form, exenatide (Byetta) or pramlintide (Symlin) within 3 months prior to screening\n* History of symptomatic heart valve disease\n* Serious or unstable current or past medical conditions","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Co-primary Endpoint- Percentage of Participants Achieving Greater Than or Equal to 5% Weight Loss From Baseline to Week 52","description":"The percentage of patients with a reduction from baseline body weight of 5% or more after 52 weeks.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37.5","spread":null},{"groupId":"OG001","value":"44.7","spread":null},{"groupId":"OG002","value":"16.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change in Body Weight From Baseline to Week 52","description":"The percent change in body weight (kg) from baseline to week 52.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.54","spread":"0.35"},{"groupId":"OG001","value":"-4.97","spread":"0.54"},{"groupId":"OG002","value":"-1.48","spread":"0.36"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":16,"n":256},"commonTop":["Hypoglycemia","Upper respiratory tract infection","Nasopharyngitis","Headache","Back pain"]}}}